Diamyd Medical arranges a two days Investigator Meeting for the European Phase II study DIAGNODE-2 attended by investigators, diabetes nurses, study managers and coordinators from Czech Republic, Sweden and Spain.
Professor Johnny Ludvigsson, Coordinating Investigator of the diabetes trial DIAGNODE-2, is leading the meeting held in Barcelona, Spain. The participants are presented to trial design, protocol and study management as a part of the preparation of the trial start and patient recruitment.
About DIAGNODE-2
The placebo controlled phase II clinical trial DIAGNODE-2 will include approximately 80 patients from Spain, the Czech Republic and Sweden aged 12-24 years, recently diagnosed with type 1 diabetes. The patients will be followed for 15 months with the aim to evaluate the remaining insulin producing capacity.
Investigators, nurses, CRAs, study coordinators and managers from Spain, Czech republic and Sweden participating in the DIAGNODE-2 Investigators Meeting arranged by the trial sponsor Diamyd Medical, held in Barcelona 5-6 October 2017.